Developing a new technology for quick and affordable breast cancer biomarker testing
Highly Integrated Nucleic-Acid Analysis Using Graphene Bioelectronics
This study is working on a new, easy-to-use device that can quickly check for important markers in your blood that help detect breast cancer and other diseases, making it faster and cheaper to get results right when you need them.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-10757940 on NIH RePORTER |
What this research studies
This research focuses on creating an innovative platform that uses graphene bioelectronics to analyze circulating microRNAs in blood samples, which are important biomarkers for breast cancer and other diseases. The goal is to enable rapid, point-of-care testing that is both cost-effective and efficient, reducing the time for results from hours to under 40 minutes and the cost to less than $10 per test. By integrating the processes of isolating, concentrating, and quantifying microRNAs into a single device, this research aims to improve accessibility to critical diagnostic information for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing evaluation for breast cancer or those with a family history of the disease who may benefit from early detection.
Not a fit: Patients who are not affected by breast cancer or do not have risk factors for the disease may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more affordable testing for breast cancer biomarkers, leading to earlier detection and better treatment options.
How similar studies have performed: Other research has shown promise in using nanotechnology and bioelectronics for biomarker analysis, indicating that this approach could lead to significant advancements in diagnostic testing.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Ping, Jinglei — University of Massachusetts Amherst
- Study coordinator: Ping, Jinglei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.